4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000109
Director acquired 6,617 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2023-10-02 | Grant or award | +6,617 | $1.70 | $11,249 | 109,237 | D |
Loading xslF345X05/wk-form4_1696364878.xml…